ErbB4, the sole member of the EGFR family with an expression that bears positive prognostic value to breast cancer patients and suppresses proliferation and promotes apoptosis [27,28], was not detected in the bitransgenic tumours (Figure 3g). The gene discussed is EGFR; the disease is breast carcinoma.